Technology Insight: emerging techniques to predict response to preoperative chemotherapy in breast cancer
- 1 November 2004
- journal article
- review article
- Published by Springer Science and Business Media LLC in Nature Clinical Practice Oncology
- Vol. 1 (1), 44-50
- https://doi.org/10.1038/ncponc0025
Abstract
No abstract availableKeywords
This publication has 32 references indexed in Scilit:
- Breast Conservation After Neoadjuvant Chemotherapy: The M.D. Anderson Cancer Center ExperienceJournal of Clinical Oncology, 2004
- Pharmacoproteomic analysis of prechemotherapy and postchemotherapy plasma samples from patients receiving neoadjuvant or adjuvant chemotherapy for breast carcinomaCancer, 2004
- Meeting Highlights: Updated International Expert Consensus on the Primary Therapy of Early Breast CancerJournal of Clinical Oncology, 2003
- Combined modality management of breast cancer: development of predictive markers through proteomicsSeminars in Oncology, 2003
- International Expert Panel on the Use of Primary (Preoperative) Systemic Treatment of Operable Breast Cancer: Review and RecommendationsJournal of Clinical Oncology, 2003
- Estimating Dataset Size Requirements for Classifying DNA Microarray DataJournal of Computational Biology, 2003
- Correlation between HER‐2 expression and response to neoadjuvant chemotherapy with 5‐fluorouracil, doxorubicin, and cyclophosphamide in patients with breast carcinomaCancer, 2003
- A Paradigm for Class Prediction Using Gene Expression ProfilesJournal of Computational Biology, 2002
- Polychemotherapy for early breast cancer: an overview of the randomised trialsThe Lancet, 1998
- Pathologic Predictors of Tumor Response to Preoperative Chemotherapy in Locally Advanced Breast CarcinomaThe Breast Journal, 1995